Vitamin D for stroke recovery after brain bleed
Treatments studied
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether vitamin D supplements can help people recover after a specific type of stroke (intracerebral hemorrhage). It is for adults who had a moderate-sized bleed in the upper part of the brain within the last 4 days and were otherwise independent before the stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You had a stroke caused by bleeding in the brain (spontaneous intracerebral hemorrhage).
- You are 18 years or older.
- The bleeding started within the last 4 days (96 hours).
- Before the stroke, you were able to walk and take care of most daily tasks (Modified Rankin Scale score of 0, 1, or 2).
- The bleeding is in the upper part of the brain (supratentorial) and is at least 2 mL in size.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a drug called Cerebrolysin, which may help protect the brain after a bleeding stroke. It is given within 6 hours of the stroke, and researchers will check if it is safe and helps improve recovery.
This trial tests whether a medicine called a GLP-1 receptor agonist (similar to diabetes drugs) can improve recovery after a specific type of bleeding stroke. The study aims to see if this drug can reduce brain swelling and help patients regain function.
This study looks at how inflammation and the brain's protective barrier are affected after a hemorrhagic stroke. It uses special brain scans to see these changes, which might help guide future care.
This study looks at what happens to people after a bleed in the brain. It will help doctors understand how people recover, so they can improve care for future patients.
This trial compares two medicines (deferoxamine and colchicine) to see if they can prevent further brain damage after a spontaneous brain bleed (intracerebral hemorrhage). The goal is to improve recovery by reducing inflammation and iron-related damage.
This trial studies whether continuing or stopping statin medicine after a spontaneous bleeding stroke in the brain (called lobar ICH) leads to better outcomes. It may help clarify if statins are safer to stay on—or better to pause—after this type of event.
Hear when a new Intracerebral Hemorrhage trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.